Medication errors during treatment with new oral anticancer agents: consequences for clinical practice based on the AMBORA Study.

Building on prior research, this study found that medication errors are common in patients starting new oral anticancer therapy. Nearly two-thirds of these medication errors involved concomitantly administered medications (e.g., other prescribed drugs, over-the-counter medications).